Lupus Landmark Study Aims for Personalized Medicine Goals

Lupus Landmark Study Aims for Personalized Medicine Goals ... A new prospective, observational study from the Lupus Research Alliance (LRA) aims ...

Lupus landmark study aims for personalized medicine goals | MDedge

A new prospective, observational study from the Lupus Research Alliance (LRA) aims to enroll 3,500 patients in an effort to accelerate the development of ...

Lupus Landmark Study Aims for Personalized Medicine Goals. Post navigation. Lupus Research Alliance (LRA) is Pleased to Announce the appointment of Stacie J.

Lupus Research Alliance and its Clinical Research Affiliate Lupus ...

May 23, 2023 – The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics launched the Lupus Landmark Study, a groundbreaking ...

Lupus Landmark Study

The Lupus Landmark Study (LLS) is a groundbreaking initiative designed to accelerate the development of personalized treatments for people living with lupus ...

Lupus Landmark Study launched to accelerate the development of ...

The aim of the Lupus Nexus is to transform lupus research and drug development through unprecedented information exchange capabilities. The ...

Landmark Study May Pave the Way for Personalized Treatment of ...

New research that may dramatically improve drug development for systemic lupus erythematosus patients will be published in Cell, the most ...

Lupus Research Alliance announces largest prospective study of ...

This study, in turn, will act as a “key component” of the Lupus Nexus, a patient-centric, collaborative registry aimed at improving lupus ...

Lupus Research Alliance and its Clinical Research Affiliate Lupus ...

Scientists will correlate deidentified data from the Landmark Study with analyzed biosample data to identify or validate drug targets, ...

Lupus Research Alliance Launches Landmark Study to Speed ...

Lupus Research Alliance Launches Landmark Study to Speed Personalized Drug Development ... NEW YORK – The nonprofit Lupus Research Alliance and ...

Lupus Landmark Study launched to improve research, personalized...

The Lupus Research Alliance (LRA) and its clinical research affiliate, Lupus Therapeutics, have launched the largest, long-term prospective ...

Action Plan for Lupus Research

The goals of treatments for lupus typically have focused on decreasing inflammation and pain while preventing tissue damage and complications.

CLINICAL TRIAL / NCT05934149 - UChicago Medicine

Lupus Nexus Landmark Study: A Prospective Registry and Biorepository ... The purpose of the registry and biorepository is to provide a mechanism to store clinical ...

Lupus Landmark Study Aims for Personalized Medicine Goals

The Lupus Landmark Study was designed as part of the Lupus Nexus, a combination registry, biorepository, and data portal. Medscape Medical ...

Lupus & Connective Tissue Diseases | MDedge Rheumatology

... Lupus landmark study aims for personalized medicine goals. Author: Heidi Splete. Publish date: May 24, 2023. The Lupus Landmark Study was designed as part of ...

Rheumatology Summit Tackles Racial Disparities in Lupus Trials

The Lupus Research Alliance and its clinical affiliate Lupus Therapeutics have launched two initiatives. One is a program called Project Change ...

LUPUS NEXUS LANDMARK STUDY: A PROSPECTIVE REGISTRY ...

The study aims to transform lupus research and drug development through the creation of a research platform. The platform will be a source of important clinical ...

Leveraging Heterogeneity in Systemic Lupus Erythematosus for ...

We critically examine the pipeline of SLE drugs, including past failures and their associated lessons and current promising approaches. Finally, we identify ...

Development of lupus biorepository underway at Lupus Center at ...

The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics launched the Lupus Landmark Study and the nationwide ...

Breakthrough Discovery in Lupus Reveals New Potential Reversal ...

Northwestern Medicine and Brigham and Women's Hospital scientists have discovered a molecular defect that promotes the pathologic immune ...